GSK: first shipments of flu vaccines to the US
(CercleFinance.com) - GSK announced on Thursday that it has begun shipping its influenza vaccines to the US for the season starting this fall and ending next year.
Following US FDA approval, GSK plans to supply some 36 million doses of its trivalent influenza A and B vaccines Flulaval and Fluarix, for adults and children over six months of age, to health centers and pharmacies nationwide.
The CDC estimates that during the last season, which ran from October 2023 to June 2024, between 35 and 65 million Americans were affected by influenza, resulting in between 390,000 and 830,000 hospitalizations and between 25,000 and 72,000 deaths.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Following US FDA approval, GSK plans to supply some 36 million doses of its trivalent influenza A and B vaccines Flulaval and Fluarix, for adults and children over six months of age, to health centers and pharmacies nationwide.
The CDC estimates that during the last season, which ran from October 2023 to June 2024, between 35 and 65 million Americans were affected by influenza, resulting in between 390,000 and 830,000 hospitalizations and between 25,000 and 72,000 deaths.
Copyright (c) 2024 CercleFinance.com. All rights reserved.